Literature DB >> 21969594

Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ.

Peter Sass1, Michaele Josten, Kirsten Famulla, Guido Schiffer, Hans-Georg Sahl, Leendert Hamoen, Heike Brötz-Oesterhelt.   

Abstract

The worldwide spread of antibiotic-resistant bacteria has lent urgency to the search for antibiotics with new modes of action that are devoid of preexisting cross-resistances. We previously described a unique class of acyldepsipeptides (ADEPs) that exerts prominent antibacterial activity against Gram-positive pathogens including streptococci, enterococci, as well as multidrug-resistant Staphylococcus aureus. Here, we report that ADEP prevents cell division in Gram-positive bacteria and induces strong filamentation of rod-shaped Bacillus subtilis and swelling of coccoid S. aureus and Streptococcus pneumoniae. It emerged that ADEP treatment inhibits septum formation at the stage of Z-ring assembly, and that central cell division proteins delocalize from midcell positions. Using in vivo and in vitro studies, we show that the inhibition of Z-ring formation is a consequence of the proteolytic degradation of the essential cell division protein FtsZ. ADEP switches the bacterial ClpP peptidase from a regulated to an uncontrolled protease, and it turned out that FtsZ is particularly prone to degradation by the ADEP-ClpP complex. By preventing cell division, ADEP inhibits a vital cellular process of bacteria that is not targeted by any therapeutically applied antibiotic so far. Their unique multifaceted mechanism of action and antibacterial potency makes them promising lead structures for future antibiotic development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969594      PMCID: PMC3198362          DOI: 10.1073/pnas.1110385108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Tubulin and FtsZ form a distinct family of GTPases.

Authors:  E Nogales; K H Downing; L A Amos; J Löwe
Journal:  Nat Struct Biol       Date:  1998-06

2.  Crystal structure of the bacterial cell-division protein FtsZ.

Authors:  J Löwe; L A Amos
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

3.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

4.  The interplay of ClpXP with the cell division machinery in Escherichia coli.

Authors:  Jodi L Camberg; Joel R Hoskins; Sue Wickner
Journal:  J Bacteriol       Date:  2011-02-11       Impact factor: 3.490

5.  Two-week inhalation toxicity of polymeric diphenylmethane-4, 4'-diisocyanate (PMDI) in rats: analysis of biochemical and morphological markers of early pulmonary response.

Authors:  J Pauluhn; M Emura; U Mohr; A Popp; M Rosenbruch
Journal:  Inhal Toxicol       Date:  1999-12       Impact factor: 2.724

6.  ClpP of Bacillus subtilis is required for competence development, motility, degradative enzyme synthesis, growth at high temperature and sporulation.

Authors:  T Msadek; V Dartois; F Kunst; M L Herbaud; F Denizot; G Rapoport
Journal:  Mol Microbiol       Date:  1998-03       Impact factor: 3.501

7.  Loss-of-function mutations in yjbD result in ClpX- and ClpP-independent competence development of Bacillus subtilis.

Authors:  M M Nakano; F Hajarizadeh; Y Zhu; P Zuber
Journal:  Mol Microbiol       Date:  2001-10       Impact factor: 3.501

8.  The FtsZ protein of Bacillus subtilis is localized at the division site and has GTPase activity that is dependent upon FtsZ concentration.

Authors:  X Wang; J Lutkenhaus
Journal:  Mol Microbiol       Date:  1993-08       Impact factor: 3.501

9.  Stress induction of the Bacillus subtilis clpP gene encoding a homologue of the proteolytic component of the Clp protease and the involvement of ClpP and ClpX in stress tolerance.

Authors:  U Gerth; E Krüger; I Derré; T Msadek; M Hecker
Journal:  Mol Microbiol       Date:  1998-05       Impact factor: 3.501

10.  Identification and characterization of the first class of potent bacterial acetyl-CoA carboxylase inhibitors with antibacterial activity.

Authors:  Christoph Freiberg; Nina A Brunner; Guido Schiffer; Thomas Lampe; Jens Pohlmann; Michael Brands; Martin Raabe; Dieter Häbich; Karl Ziegelbauer
Journal:  J Biol Chem       Date:  2004-04-02       Impact factor: 5.157

View more
  55 in total

1.  Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus.

Authors:  Trent Kunkle; Sanofar Abdeen; Nilshad Salim; Anne-Marie Ray; Mckayla Stevens; Andrew J Ambrose; José Victorino; Yangshin Park; Quyen Q Hoang; Eli Chapman; Steven M Johnson
Journal:  J Med Chem       Date:  2018-11-15       Impact factor: 7.446

2.  Structural basis of mycobacterial inhibition by cyclomarin A.

Authors:  Dileep Vasudevan; Srinivasa P S Rao; Christian G Noble
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

3.  Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease.

Authors:  Kirsten Famulla; Peter Sass; Imran Malik; Tatos Akopian; Olga Kandror; Marina Alber; Berthold Hinzen; Helga Ruebsamen-Schaeff; Rainer Kalscheuer; Alfred L Goldberg; Heike Brötz-Oesterhelt
Journal:  Mol Microbiol       Date:  2016-04-01       Impact factor: 3.501

4.  Reversible inhibition of the ClpP protease via an N-terminal conformational switch.

Authors:  Siavash Vahidi; Zev A Ripstein; Massimiliano Bonomi; Tairan Yuwen; Mark F Mabanglo; Jordan B Juravsky; Kamran Rizzolo; Algirdas Velyvis; Walid A Houry; Michele Vendruscolo; John L Rubinstein; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

Review 5.  Artificial activation of toxin-antitoxin systems as an antibacterial strategy.

Authors:  Julia J Williams; Paul J Hergenrother
Journal:  Trends Microbiol       Date:  2012-03-22       Impact factor: 17.079

6.  Sulfonamido-2-arylbenzoxazole GroEL/ES Inhibitors as Potent Antibacterials against Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Sanofar Abdeen; Trent Kunkle; Nilshad Salim; Anne-Marie Ray; Najiba Mammadova; Corey Summers; Mckayla Stevens; Andrew J Ambrose; Yangshin Park; Peter G Schultz; Arthur L Horwich; Quyen Q Hoang; Eli Chapman; Steven M Johnson
Journal:  J Med Chem       Date:  2018-08-14       Impact factor: 7.446

7.  Examination of a Structural Model of Peptidomimicry by Cyclic Acyldepsipeptide Antibiotics in Their Interaction with the ClpP Peptidase.

Authors:  Daniel W Carney; Karl R Schmitz; Anthony C Scruse; Robert T Sauer; Jason K Sello
Journal:  Chembiochem       Date:  2015-07-27       Impact factor: 3.164

8.  Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections.

Authors:  Alex Washburn; Sanofar Abdeen; Yulia Ovechkina; Anne-Marie Ray; Mckayla Stevens; Siddhi Chitre; Jared Sivinski; Yangshin Park; James Johnson; Quyen Q Hoang; Eli Chapman; Tanya Parish; Steven M Johnson
Journal:  Bioorg Med Chem Lett       Date:  2019-04-24       Impact factor: 2.823

9.  Life and death of proteins: a case study of glucose-starved Staphylococcus aureus.

Authors:  Stephan Michalik; Jörg Bernhardt; Andreas Otto; Martin Moche; Dörte Becher; Hanna Meyer; Michael Lalk; Claudia Schurmann; Rabea Schlüter; Holger Kock; Ulf Gerth; Michael Hecker
Journal:  Mol Cell Proteomics       Date:  2012-05-03       Impact factor: 5.911

10.  Specificity Distorted: Chemical Induction of Biological Paracatalysis.

Authors:  Brian P Callahan; Daniel A Ciulla; Andrew G Wagner; Zihan Xu; Xiaoyu Zhang
Journal:  Biochemistry       Date:  2020-09-15       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.